These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 12751740)

  • 1. Arachidonic acid inhibits cysteinyl-leukotriene receptor activation in human pulmonary vessels.
    Walch L; Norel X; Gascard JP; Brink C
    Adv Exp Med Biol; 2003; 525():75-9. PubMed ID: 12751740
    [No Abstract]   [Full Text] [Related]  

  • 2. Studies of receptors and modulatory mechanisms in functional responses to cysteinyl-leukotrienes in smooth muscle.
    Bäck M
    Acta Physiol Scand Suppl; 2002 Feb; 648():1-55. PubMed ID: 11913222
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacological evidence for a novel cysteinyl-leukotriene receptor subtype in human pulmonary artery smooth muscle.
    Walch L; Norel X; Bäck M; Gascard JP; Dahlén SE; Brink C
    Br J Pharmacol; 2002 Dec; 137(8):1339-45. PubMed ID: 12466244
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Functional studies of leukotriene receptors in vascular tissues.
    Walch L; Norel X; Gascard JP; Brink C
    Am J Respir Crit Care Med; 2000 Feb; 161(2 Pt 2):S107-11. PubMed ID: 10673237
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of montelukast, a cysteinyl-leukotriene type 1 receptor antagonist, on the pathogenesis of bleomycin-induced pulmonary fibrosis in mice.
    Shimbori C; Shiota N; Okunishi H
    Eur J Pharmacol; 2011 Jan; 650(1):424-30. PubMed ID: 21034736
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Leukotriene receptors on human pulmonary vascular endothelium.
    Ortiz JL; Gorenne I; Cortijo J; Seller A; Labat C; Sarria B; Abram TS; Gardiner PJ; Morcillo E; Brink C
    Br J Pharmacol; 1995 Aug; 115(8):1382-6. PubMed ID: 8564195
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cyclooxygenase dependent formation of 8-iso-prostaglandin F2 alpha by human platelets.
    Pratico D; Lawson JA; Fitzgerald GA
    Adv Prostaglandin Thromboxane Leukot Res; 1995; 23():229-31. PubMed ID: 7732840
    [No Abstract]   [Full Text] [Related]  

  • 8. Evidence for a dilator function of 8-iso prostaglandin F2 alpha in rat pulmonary artery.
    Jourdan KB; Evans TW; Curzen NP; Mitchell JA
    Br J Pharmacol; 1997 Apr; 120(7):1280-5. PubMed ID: 9105703
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Isoprostanes and PGE2 production in human isolated pulmonary artery smooth muscle cells: concomitant and differential release.
    Jourdan KB; Evans TW; Goldstraw P; Mitchell JA
    FASEB J; 1999 Jun; 13(9):1025-30. PubMed ID: 10336884
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prostacyclin release and receptor activation: differential control of human pulmonary venous and arterial tone.
    Norel X; Walch L; Gascard JP; deMontpreville V; Brink C
    Br J Pharmacol; 2004 Jun; 142(4):788-96. PubMed ID: 15172959
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Arachidonic acid inhibits Na⁺-K⁺-ATPase via cytochrome P-450, lipoxygenase and protein kinase C-dependent pathways in sheep pulmonary artery.
    Singh TU; Choudhury S; Parida S; Maruti BS; Mishra SK
    Vascul Pharmacol; 2012; 56(1-2):84-90. PubMed ID: 22155164
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Involvement of TP and EP3 receptors in vasoconstrictor responses to isoprostanes in pulmonary vasculature.
    Janssen LJ; Tazzeo T
    J Pharmacol Exp Ther; 2002 Jun; 301(3):1060-6. PubMed ID: 12023538
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The cysteinyl-leukotriene-1 receptor antagonist zafirlukast is a potent secretagogue in rat and human airways.
    Schmidt R; Staats P; Groneberg DA; Wagner U
    Eur J Pharmacol; 2005 Dec; 527(1-3):150-6. PubMed ID: 16310765
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A kinetic binding study to evaluate the pharmacological profile of a specific leukotriene C(4) binding site not coupled to contraction in human lung parenchyma.
    Ravasi S; Capra V; Mezzetti M; Nicosia S; Rovati GE
    Mol Pharmacol; 2000 Jun; 57(6):1182-9. PubMed ID: 10825389
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of 5-HT receptors on human pulmonary artery and vein: functional and binding studies.
    Cortijo J; Martí-Cabrera M; Bernabeu E; Domènech T; Bou J; Fernández AG; Beleta J; Palacios JM; Morcillo EJ
    Br J Pharmacol; 1997 Dec; 122(7):1455-63. PubMed ID: 9421295
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Functional characterisation of receptors for cysteinyl leukotrienes in smooth muscle.
    Jonsson EW
    Acta Physiol Scand Suppl; 1998 Mar; 641():1-55. PubMed ID: 9597121
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Release of isoprostanes by human pulmonary artery in organ culture: a cyclo-oxygenase and nitric oxide dependent pathway.
    Jourdan KB; Mitchell JA; Evans TW
    Biochem Biophys Res Commun; 1997 Apr; 233(3):668-72. PubMed ID: 9168911
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cysteinyl-leukotriene 1 receptor antagonist attenuates bleomycin-induced pulmonary fibrosis in mice.
    Izumo T; Kondo M; Nagai A
    Life Sci; 2007 Apr; 80(20):1882-6. PubMed ID: 17397875
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Urinary leukotriene E4.
    Rabinovitch N
    Immunol Allergy Clin North Am; 2007 Nov; 27(4):651-64; vii. PubMed ID: 17996582
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hypoxia-induced hyperreactivity of pulmonary arteries: role of cyclooxygenase-2, isoprostanes, and thromboxane receptors.
    Delannoy E; Courtois A; Freund-Michel V; Leblais V; Marthan R; Muller B
    Cardiovasc Res; 2010 Feb; 85(3):582-92. PubMed ID: 19710084
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.